SE0301888D0 - New use VII - Google Patents

New use VII

Info

Publication number
SE0301888D0
SE0301888D0 SE0301888A SE0301888A SE0301888D0 SE 0301888 D0 SE0301888 D0 SE 0301888D0 SE 0301888 A SE0301888 A SE 0301888A SE 0301888 A SE0301888 A SE 0301888A SE 0301888 D0 SE0301888 D0 SE 0301888D0
Authority
SE
Sweden
Prior art keywords
lt
gt
new use
11beta
wound healing
Prior art date
Application number
SE0301888A
Other languages
Swedish (sv)
Inventor
Cecilia Nilsson
Catrine Nilsson
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0301888A priority Critical patent/SE0301888D0/en
Publication of SE0301888D0 publication Critical patent/SE0301888D0/en

Links

Abstract

The invention relates to a method for promoting wound healing, said method comprising administering to a mammal, including man, in need of such promotion an effective amount of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1), said 11beta-HSD1 inhibitor having the formula (I) wherein T, B<1>, B<2>, B<3> and R<1> are as defined in the specification. These compounds may also be used in the manufacture of a medicament for promoting wound healing.
SE0301888A 2003-06-25 2003-06-25 New use VII SE0301888D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE0301888A SE0301888D0 (en) 2003-06-25 2003-06-25 New use VII

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0301888A SE0301888D0 (en) 2003-06-25 2003-06-25 New use VII
PCT/SE2004/000994 WO2004112779A1 (en) 2003-06-25 2004-06-21 New use vii

Publications (1)

Publication Number Publication Date
SE0301888D0 true SE0301888D0 (en) 2003-06-25

Family

ID=27656623

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301888A SE0301888D0 (en) 2003-06-25 2003-06-25 New use VII

Country Status (2)

Country Link
SE (1) SE0301888D0 (en)
WO (1) WO2004112779A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8686011B2 (en) 2004-05-24 2014-04-01 Amgen Inc. Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
CN1964956B (en) 2004-05-24 2013-03-27 安美基公司 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2006105127A2 (en) 2005-03-31 2006-10-05 Takeda San Diego, Inc. Hydroxysteroid dehydrogenase inhibitors
US7622492B2 (en) 2005-08-31 2009-11-24 Hoffmann-La Roche Inc. Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
WO2007061661A2 (en) 2005-11-22 2007-05-31 Amgen Inc. Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MX2009001043A (en) 2006-08-08 2009-02-06 Sanofi Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use.
DE102007005045B4 (en) 2007-01-26 2008-12-18 Sanofi-Aventis Phenothiazine derivatives, process for their preparation and their use as medicines
US8802660B2 (en) * 2007-03-12 2014-08-12 New York University De novo synthesis of glucocorticoids in the epidermis and its uses and applications
ES2340640T3 (en) 2007-03-23 2010-06-07 Icagen, Inc. Ion channel inhibitors.
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
AR072707A1 (en) 2008-07-09 2010-09-15 Sanofi Aventis heterocyclic compounds, processes for their preparation, medicaments comprising these compounds and the use thereof
US20100022572A1 (en) 2008-07-18 2010-01-28 Kowa Company, Ltd. Novel spiro compound and medicine comprising the same
WO2010023931A1 (en) 2008-08-29 2010-03-04 興和株式会社 1-adamantylazetidin-2-one derivative and pharmaceutical preparation comprising same
JP5477973B2 (en) 2008-10-29 2014-04-23 興和株式会社 1,2-diazetidin-3-one derivative and medicament containing the same
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
US8785608B2 (en) 2009-08-26 2014-07-22 Sanofi Crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
WO2011157827A1 (en) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2766349B1 (en) 2011-03-08 2016-06-01 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
US8809324B2 (en) 2011-03-08 2014-08-19 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683699B1 (en) 2011-03-08 2015-06-24 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8809325B2 (en) 2011-03-08 2014-08-19 Sanofi Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
EP2683704B1 (en) 2011-03-08 2014-12-17 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683705B1 (en) 2011-03-08 2015-04-22 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120058A1 (en) 2011-03-08 2012-09-13 Sanofi Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8895547B2 (en) 2011-03-08 2014-11-25 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CN107921034A (en) * 2015-08-11 2018-04-17 康内克斯生命科学私人有限公司 The method of wound healing
EP3235813A1 (en) 2016-04-19 2017-10-25 Cidqo 2012, S.L. Aza-tetra-cyclo derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH10639A (en) * 1967-07-17 1977-07-22 Research Corp Method of treatment and composition containing silver sulfadiazine
DE69628740T2 (en) * 1995-04-04 2004-05-13 Encysive Pharmaceuticals Inc., Bellaire Thienyl, furyl, pyrrolyl and biphenylsulfonamide and derivatives for the modulation of endothelin-activity
AU743898B2 (en) * 1996-10-16 2002-02-07 American Cyanamid Company The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
CA2466733A1 (en) * 2001-11-22 2003-05-30 Meredith Williams Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

Also Published As

Publication number Publication date
WO2004112779A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
RU2264389C2 (en) Nitrogen-containing aromatic derivatives, their using, medicinal agent based on thereof and method for treatment
CR8086A (en) 1,2,4-oxadiazole compounds of benzoic acid and its use for suppression of nonsense mutations
CY1108393T1 (en) INHIBITORS dipeptidyl peptidasis
NO332195B1 (en) A purine compound as well as pharmaceutical compositions containing the same
CY1108754T1 (en) New derivatives theiofainoglykosidis, METHOD for their preparation, medicines contain THESE COMPOUNDS AND THEIR USE
NO20070606L (en) Inhibitors of IAP
UY27169A1 (en) Isophthalic acid derivatives as inhibitors of matrix metalloproteinases
CY1108146T1 (en) INHIBITORS OF B-AMINO-ETEROKYKLIKIS-DIPEPTIDYLIKIS PEPTIDASIS FOR TREATMENT OR PREVENTION OF DIABETES
IS8398A (en) Formulations for the treatment of neoplastic
BR9913255A (en) The compound, pharmaceutical composition, process of treatment of a condition mediated by metalloproteinase disease, a process for preparing a compound, and use of a compound
BRPI0409227B8 (en) &#34;Compound, pharmaceutical composition, use of a compound and method for the preparation of a compound of formula (I)&#34;
YU64701A (en) Compounds useful as anti-inflamatory agents
NO20032233D0 (en) Synergistic associations comprising a renin inhibitor for kardiovaskul¶re diseases
CY1110322T1 (en) INHIBITORS her3 ACTIVITY
RU2003116896A (en) Synergistic compositions comprising a renin inhibitor for the treatment of cardiovascular diseases
PL402389A1 (en) Method for inhibiting Raf kinase activity in humans or inanimals
SE0302486D0 (en) Novel compounds
RU95109920A (en) Derivatives of hydroxamic acid as metalloproteinase inhibitors
BR0109703A (en) piperazine derivatives
SE0000540D0 (en) New compounds
MEP13008A (en) C-aryl glucoside sglt2 inhibitors and method
BR9916282A (en) Compound, use of a a compound and method of treatment
CY1111143T1 (en) Kyanopyridinis novel derivatives useful in the treatment of cancer and other disorders
CY1112297T1 (en) Heterocyclic MEK INHIBITORS AND METHODS OF USE these
SE0102299D0 (en) Compounds